http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78c5cdd0e000f08a156fa38318ac95d5
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Waxman |
| name | Samuel Waxman |
| given-name | Samuel |
| organization-name | From the Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Second Medical University, the Institute of Cell Biology, Chinese Academy of Sciences, and the Chinese National Human Genome Center at Shanghai, Shanghai, China; Clontech Laboratories, Palo Alto, CA; the Division of Neoplastic Diseases, Department of Medicine, Mount Sinai Medical Center, New York, NY; and Institute National de la Santé et de la Recherche Medicalé(INSERM) Unité, Hospital Saint Louis, Paris, France. 8Department of Medicine, Mount Sinai School of Medicine, New York, New York 3Departments of Medicine From the Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montréal, Québec, Canada, and Mount Sinai School of Medicine, New York, NY. 7Division of Hematology/Oncology, Department of Medicine, Division of Hematology/Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, New York From the Rochelle Belfer Chemotherapy Foundation Laboratory, Division of Neoplastic Diseases, Department of Medicine, and the Department of Neurology, Mount Sinai Medical Center, New York, NY. Division of Hematology/Oncology and 3Department of Medicine, Mount Sinai School of Medicine, New York, New York; and Cancer Chemotherapy Laboratory, Department of Medicine, Mount Sinai School of Medicine of the City University of New York, N.Y. 10029 Shanghai Institute of Hematology, State Key Lab of Medical Genomics, Rui Jin Hospital affiliated with Shanghai Second Medical University, 197 Rui Jin Road II, Shanghai 200025, China; Centre National de la Recherche Scientifique, Unité Propre de Recherche 9051, Laboratoire Associé du Comité de Paris de la Ligue Contre le Cancer, Affilié à l'Université de Paris VII, Hôpital St. Louis, 1 Avenue C. Vellefaux, 75475 Paris Cedex 10, France; and Division of Neoplastic Diseases, Department of Medicine,... Cancer Chemotherapy Foundation Laboratory, Division of Medical Oncology, Mount Sinai School of Medicine, City University of New York, New York 10029 Authors' Affiliations: 1Hematology/Oncology Section, Department of Medicine, 2Norris Cotton Cancer Center, Departments of 3Pharmacology and Toxicology, 4Pathology, 5Radiology, and 6Surgery, Dartmouth Medical School (Hanover) and Dartmouth-Hitchcock Medical Center (Lebanon); 7Dartmouth College, Hanover, New Hampshire; 8MD Anderson Cancer Center, Houston, Texas; and 9Mount Sinai School of Medicine, New York, New York From the Department of Medicine, Division of Medical Oncology, Mount Sinai School of Medicine, New York, NY; the Shanghai Institute of Hematology, Shanghai Second Medical University, Shanghai, China; and Lady Davis Institute for Medical Research, McGill University, Montreal, QC, Canada. Department of Medicine, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA 1Division of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029; and The Division of Hematology/Oncology, Department of Medicine, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Department of Medicine, Mount Sinai School of Medicine, New York, NY 5Department of Medicine, Mount Sinai School of Medicine, New York, New York; and Samuel Waxman Cancer Research Foundation Joint Translational Research Center, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 2Division of Hematology/Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, New York From the Leukaemia Research Fund Centre at the Institute of Cancer Research, Chester Beatty Laboratories, London, UK; the Department of Cell Biology, Faculty of Health Sciences, University of Linköping, Linköping, Sweden; and the Department of Medicine, Mount Sinai School of Medicine, New York, NY. From Shanghai Institute of Hematology, Department of Hematology/Oncology, Rui Jin Hospital/Samuel Waxman Cancer Research Foundation Joint Center for Cancer Differentiation Therapy Sponsored by Reliance Group Holdings Inc, Rui-Jin Hospital, Ren-Ji Hospital; Xin-Hua Hospital, Shanghai Second Medical University, Shanghai, China; Zhong-Shan Hospital, Shanghai, China; Gan-Quan Hospital, Shanghai, China; and First Hospital Affiliated with Harbin Medical University, Harbin, China. Division of Hematology and Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA Key Laboratory of Genome Research, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Second Medical University, Shanghai, 200025, People’s Republic of China; Hôpital Saint-Louis and Centre d’Etude du Polymorphisme Humain, Institut de Génétique Moléculaire, Paris, 75010, France; Mount Sinai Medical Center, New York, NY 10029; and Institute of Genetics, Fudan University, Shanghai, 200433, People’s Republic of China 3Mount Sinai School of Medicine, New York, New York; and 5Department of Medicine, Mount Sinai School of Medicine, New York, New York Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA From the Department of Medicine, Division of Hematology/Oncology, Mount Sinai School of Medicine, New York, NY; the Department of Pediatrics and Nutrition, University of North Carolina, Chapel Hill; and the Shanghai Institute of Hematology, Rui-Jin Hospital, Shanghai Second Medical University, China. Authors' Affiliations: 1The Division of Hematology/Oncology, Department of Medicine, The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York; and 2School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong, China 1Division of Hematology/Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, New York and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA From the Rochelle Belfer Chemotherapy Foundation Laboratory, the Division of Neoplastic Diseases, the Division of Hematology, the Department of Medicine, Mount Sinai Medical Center, New York, NY. State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Second Medical University, 197 Rui Jin Road II, Shanghai 200025, China; Health Science Center, Shanghai Institutes of Biological Science, Chinese Academy of Science and Shanghai Second Medical University, 225 South Chong Qing Road, Shanghai 200025, China; Department of Clinical Laboratory, Union Hospital, Fujian Medical University, 29 Xinquan Road, Fuzhou, Fujian 350001, China; National Engineering Center for Biochip at Shanghai,... Authors' Affiliations: 1Division of Hematology/Oncology, Tisch Cancer Institute and 2Department of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York; and 3Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts 2Mount Sinai School of Medicine, New York, New York; Department of MedicineMount Sinai Medical CenterNew YorkNew York10029USA Department of Medicine, Division of Hematology and Oncology, Tisch Cancer Center, Mount Sinai School of Medicine, New York, NY 10029; and From the Division of Medical Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, NY. Cancer Chemotherapy Laboratory, Division of Oncology, Department of Medicine, Mount Sinai School of Medicine of the City University of New York, New York, N.Y. 10029.; Cancer Chemotherapy Laboratory, Division of Oncology, Department of Medicine, Mount Sinai School of Medicine of the City University of New York, New York, N. Y. 10029. Cancer Chemotherapy Laboratory, Division of Oncology, Department of Medicine, Mount Sinai School of Medicine of the City University of New York, New York, N.Y. 10029.; Cancer Chemotherapy Laboratory, Division of Oncology, Department of Medicine. Mount Sinai School of Medicine of the City University of New York, New York. N. Y. 10029. From the Shanghai Institute of Hematology and Key Laboratory for Human Genome Research, Rui Jin Hospital, Shanghai Second Medical University, Shanghai, China; INSERM U496, Centre G. Hayem, Hopital Saint Louis, Paris, France; and Division of Neoplastic Diseases, Department of Medicine, The Mount Sinai Medical Center, New York, NY. The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA 1Division of Hematology/Oncology, Department of Medicine, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, New York. Rochelle Belfer Chemotherapy Foundation Laboratory, Mt. Sinai School of Medicine, New York, New York, USA 1Division of Hematology/Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, New York; State Key Lab for Medical Genomics and Samuel Waxman Cancer Research Foundation Lab, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Second Medical University, 197 Rui Jin Road II, Shanghai 200025, China; Chinese National Human Genome Center at Shanghai, 351 Guo Shou Jing Road, Pudong, Shanghai 201203, China; State Key Lab for Genetic Engineering, FuDan University, 220 Han Dan Road, Shanghai 200433, China; Section of Infectious Disease, Department of Medicine, Baylor College of Medicine... |
Incoming Links
Total number of triples: 189.